Ruti Aga's Six-Year Ban: How a Forged Prescription Ended a 32-Year-Old Marathoner's Career

On a March morning, Ruti Aga broke the tape at a World Athletics Label half marathon in China. For an Ethiopian woman marathoner, that was not extraordinary. Aga was a 2:18-class runner, the 2026 Tokyo Marathon champion, with three World Marathon Majors podium finishes. But what emerged shortly after that victory was not a clock time. A statement from the Athletics Integrity Unit (AIU) announced that Aga had been banned for six years — two years for the presence of a prohibited substance, and four years for providing misleading information and forged documents to investigators. A knee injury, a clinic that did not exist, and a 'doctor' who was a family member with no medical registration. This is the story of a file nobody usually reads: the anti-doping disciplinary decision. I have seen many such cases from London, where the pattern is consistent — the initial mistake is small, but the attempt to hide it multiplies the sentence several times over. Aga's case belongs to that category, and it conceals a subtlety that almost no media report has properly explained. Start with the technical error, because the entire case rests on it. Reports called methylprednisolone a 'prohibited steroid' and wrote that WADA classes it as performance-enhancing. That is imprecise. Methylprednisolone is a glucocorticoid — class S9 on the WADA Prohibited List — not an anabolic steroid (S1). And the difference is legally decisive: S9 glucocorticoids are prohibited only in-competition, and only via injection, oral, or rectal routes. A therapeutic injection into the knee is entirely legal out-of-competition; it becomes a violation only if residues are present in an in-competition sample. I have listened to many athletes in the mixed zone at the 2026 London World Championships say they did not know when their injection was given and when the test would be. That ignorance is not an excuse, but it tells you where the problem lies — how weak the medical support structure around the athlete is. Had Aga had genuine medical records, she had a legitimate defence available. She destroyed that defence herself with a forged prescription. Now the arithmetic, which is buried inside the AIU statement. Two years for the 'presence' violation — meaning a prohibited substance found in the body — and four years for 'tampering.' Under the WADA Code, the standard sanction for tampering is four years, while two years for a prohibited substance is typical when the panel does not find intent and the substance is in the 'specified' category. The combination tells us the panel rejected the 'no significant fault' mitigation that could have reduced the sanction. That mitigation was the defence available: the injury was real, the treatment was necessary. But when the prescription itself turned out to be forged, the foundation of the defence collapsed. How that prescription came to be is the most striking part of this case. Aga told the AIU that a family member, who claimed to be a doctor, wrote the prescription for her knee treatment. The investigation found that the clinic named on the prescription did not exist. The family member had no medical registration. And when questioned, they said they had used 'an old prescription pad from a former workplace' — which the clinic explicitly disowned. Three independent verification failures. This is not a filing error; it is the signature of an athlete operating without a credentialed team physician. My view is that a properly managed athlete either holds a TUE or observes WADA's route-specific washout period. Neither appears to have happened here. And when caught, the solution devised was to manufacture paperwork. The panel treated the forged prescription not as a mitigating fact but as an aggravating one. Now step back a little. Aga won the 2026 Tokyo Marathon and finished second at three World Marathon Majors. That is the record of a genuinely elite marathon career. But the ban is dated from 10 September, and six years means she would return at roughly age 38. Given the depth of Ethiopian women's marathon running — where even a 2:18 performer is not automatically selected — a 38-year-old returnee with a doping record is effectively unselectable for the national team. Which means this six-year ban is functionally a lifetime ban for elite purposes. But there is an angle I want to draw your attention to. If you believe this is simply the story of one athlete's mistake, you are missing the full picture. Knee injuries are a common, recurring problem among marathoners. There is pressure to perform, pressure to protect appearance-fee income, and the cheapest, most readily available tool to mask pain is a glucocorticoid injection. When medical support is informal, manufacturing fake paperwork starts to look like a 'convenient solution.' The moment Aga had a family member write that prescription is the product of a moment when she had no credentialed medical team. If the AIU investigation stopped at Aga, the question is what role her agent or management played. Did anyone advise her on that document? The statement names only the family member. The cost is borne by the system, but the sanction falls on one athlete alone. There is a second angle, deeply uncomfortable but necessary to state. China's label half-marathon circuit has in recent years become a lucrative, low-risk income tier for East African elite runners — a way to earn appearance fees between Majors. That same tier is now the AIU's highest-yield testing ground. That is no coincidence. When large appearance fees and intensive testing coexist in the same race, the collision of incentives and surveillance is inevitable. I do not think the AIU is 'targeting East African runners,' but I do think a six-year ban for a substance with no proven endurance benefit will fuel that debate. Glucocorticoids are essential in many treatments, despite IOC-accredited laboratories and strict guidelines. I think the case for sanctioning glucocorticoids is particularly weak, because it criminalises medical treatment under the guise of fairness. But the real offence here was not the substance — the real offence was the lies and the forged documents. Let me be clear about one more thing. I believe this case proves that the frontier of anti-doping enforcement has shifted from 'catching substances' to 'verifying documents.' Aga's story is not isolated. There are many East African road-racing cases where the first violation was minor, but the attempt to conceal it multiplied the case several times over. Forged documents and misleading statements are now among the AIU's most frequently charged secondary offences. The solution is not merely to sanction the athlete, but to build a formal, accessible, and affordable medical support structure around them. Had Aga had a real doctor and a real TUE process, the six-year ban might never have come. Now the question every road-racing athlete and their manager should ask themselves after this case: when the pain is so bad you cannot race, do you have a phone number for a real doctor? If not, your career rests on an old prescription pad and an unsigned piece of paper. What Ruti Aga did in Tokyo in 2026 will remain in the record — no one can erase it. But the six-year ban also records that athletic ability and administrative strength are two sides of the same coin, and when the second is weak, the first does not survive either. The next time a champion cries at the finish line, ask first how her knee is, and who wrote her prescription — because the real battle of the marathon is sometimes not at the finish line, but at the clinic door.